Search
In this Q&A, MSK hematologic oncologist Sergio Giralt, MD, talks about a phase 3 trial of ide-cel CAR T therapy for people with recurrent multiple myeloma and what it may mean for people with this hard-to-treat blood cancer.
The awards are given annually to people in an array of fields in the arts and sciences.
A passion for both science and the humanities has informed the life and career of Dr. Ivan Maillard, who was recently selected to lead the Division of Hematologic Malignancies at MSK.
Gynecologic cancer surgeon Carol Brown featured in Crain's New York Business’ Notable Black Leaders and Executives list.
Scientists have found a protein that empowers prostate tumors to resist hormone therapy.
On Thursday, June 11, at 11:30 AM, 45 high school seniors will participate in the MSK Kids 14th Annual Convocation ceremony. Each year, MSK celebrates our youngest patients (who have all battled cancer or a blood disorder) who are receiving their high school diploma or equivalency.
Very low-dose radiotherapy (VLDRT) is effective for treating grade 3A follicular lymphoma and provides patients with a shorter treatment course and fewer side effects.
Dr. Deb Schrag, Chair of the Department of Medicine, and Dr. Lorenz Studer, Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists worldwide.
Learn about some of the most important advances in cancer treatment and clinical trials at MSK in 2024.
Memorial Sloan Kettering Cancer Center (MSK) molecular pharmacologist Daniel Heller, PhD, and colleagues have identified a new strategy to target drugs specifically to cancer sites, including metastatic tumors. The approach involves nanoparticles designed to mimic a mechanism that tumors themselves use to metastasize throughout the body. This work, which will be featured on the cover of the June 29 issue of Science Translational Medicine, was applicable across a wide range of tumor and drug types and can potentially be applied to other conditions including vascular and autoimmune diseases.